Oct. 27, 2017
by Alfred Ajami
Biopharma insight
In a case of "back to the future", chemists at Scripps collaborating with instrument engineers at IKA have unveiled a …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
June 30, 2016
by Andrii Buvailo
Biopharma insight
Increasing the success rate of high-throughput screening (HTS) and the quality of the resulting hits as well as developability of …
June 2, 2018
by Andrii Buvailo
Biopharma insight
(Edited version of this post originally appeared in Forbes) “It is not the strongest of the species that survives, nor …
Dec. 6, 2017
by Alfred Ajami
Biopharma insight
The16th century alchemical and 19th century science fiction revival of a miniature human being in a test tube is undergoing …
Aug. 18, 2017
by BiopharmaTrend
Biopharma insight
Virtual reality (VR) has been a hot topic in game industry lately, but now it finds its way to biopharmaceutical …
Feb. 20, 2019
by Andrii Buvailo
Biopharma insight
In 1970-80s, the idea of virtual screening was regarded as a conceptual way to substitute costly and time-consuming experimental “screen-everything-you-have” …
Sept. 12, 2018
by Andrii Buvailo
Biopharma insight
Today Basel is crowded with some of the top business and research leaders representing a young and rapidly growing industry …
Jan. 18, 2018
by Andrii Buvailo
Interview
The previous year was rich in discussions and events one way or another related to potential applications of artificial intelligence …
Dec. 3, 2021
by Andrii Buvailo
Biopharma insight
Getting a step closer to treating Idiopathic Pulmonary Fibrosis A Hong Kong-based company applying a state-of-the-art artificial intelligence (AI) platform …
Feb. 9, 2020
by Irina Bilous
Biopharma insight
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
Jan. 15, 2019
by Naheed Kurji
Biopharma insight
In this Special Perspective, our fourth in an ongoing series, we will be presenting MatchMaker™, a novel deep proteome screening …